申请人:Aventis Pharmaceuticals Inc.
公开号:US06329550B1
公开(公告)日:2001-12-11
The present application relates to novel aminomalonamides of the formula
and pharmaceutical composition thereof which are useful for inhibiting matrix metalloproteinases.
本申请涉及公式及其制药组合物的新型氨基丙二酰胺,其对于抑制基质金属蛋白酶具有有用性。